How Biosafety Testing Will Evolve To Meet The Needs Of Biologics Manufacturers Tomorrow

The pressure to shorten delivery times and reduce costs for biologics such as mAbs are driving an evolution in the biomanufacturing space. Ironically, where we see almost daily innovation in production technologies, many of the methods used for biosafety testing are decades old. In this talk we will explore how new methods can be used to accelerate biosafety testing today

In this webinar, you will learn about:

• The drivers behind the need for faster biosafety testing
• The opportunities today for accelerating testing
• The technologies needed to address the requirements of manufacturers tomorrow